Changing HCV genotypes distribution in Poland--relation to source and time of infection.
about
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypesReview article: HCV genotype 3 – the new treatment challengeHepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionPrevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz.Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, CaliforniaHepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in PolandMolecular and contextual markers of hepatitis C virus and drug abuse.Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.Distribution of hepatitis C virus genotypes in Iranian chronic infected patientsHEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.Hepatitis C virus infection among drug addicts in Italy.Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysisChanges in hepatitis C virus genotype distribution in Japan.Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010.
P2860
Q26781991-73E2CCBF-023E-498C-B34A-E561640904C3Q26864571-3E52F0C1-D94B-47F2-A4D1-ED9220DC9F67Q27014761-C0DB7EF0-0A05-40F5-8DCD-A8EE84DF218FQ33563427-7863F5C0-512A-4212-B458-694B90C7A48FQ33647250-B466A0FE-D2A3-4878-B8F2-A420BA420CEEQ33978978-9944E0C2-62D9-4173-9007-737F96C21D83Q34008754-8647FEC8-F78C-40B2-991E-7B1C3E128F33Q34459438-7FDCA663-A372-4AA4-BB13-CEE00423BC02Q35507630-04CDDE6E-D540-443A-BC9F-1C1F905F659BQ35660841-6994CE8D-5BE2-496C-A3FA-9B2B472ABEA5Q35920144-A24A917C-01BD-4372-874F-968C498347E3Q36607811-66FD4714-97FE-4C5A-A255-AD600D57866CQ36638642-CAB57F27-A475-4F04-90F7-40E892E70E72Q36761081-B9C078FF-2233-4DCF-8A44-948EF3BD94E1Q37349005-DB79F32D-D626-4F90-BA3F-16C8F392130DQ37886280-551FF77C-42AD-4A91-952E-FED4E54D7D33Q39494158-865A19E5-C147-4AC0-AA18-D2A6DBF6C4FAQ41008122-85E037BA-DB30-4175-BD36-6481545671A1Q42225539-F5F1D389-603C-4053-8662-4B88C9790375Q42282840-4A829BDE-2CDE-49DA-BE5E-1F328692768FQ43032801-C5A7C695-86C6-4DC9-9600-62368B7C1DF4
P2860
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@en
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@nl
type
label
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@en
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@nl
prefLabel
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@en
Changing HCV genotypes distribution in Poland--relation to source and time of infection.
@nl
P2093
P1476
Changing HCV genotypes distribution in Poland--relation to source and time of infection
@en
P2093
Barbara Pytel-Krolczuk
Danuta Prokopowicz
Lech Chyczewski
Oksana Kowalczuk
Slawomir Chlabicz
P304
P356
10.1016/J.JCV.2008.02.001
P577
2008-03-19T00:00:00Z